The COVID-19 pandemic and specialized oncology care: An experience report
DOI:
https://doi.org/10.15649/cuidarte.1377Keywords:
Safety Management, Medical Oncology, Coronavirus Infections, Ambulatory Care, PandemicsAbstract
Introduction: The COVID-19 pandemic has brought many challenges to oncology care, leading to the implementation of new operational models in health management and care. Objective: To describe the experiences related to the implementation of health management and care models in cancer treatment centers during the COVID-19 outbreak. Materials and Methods: A qualitative descriptive case report was conducted including experiences from March 5 to January 31, 2021. Reports were provided by different cancer treatment centers in São Paulo, Brazil. Results: Actions such as identification of patients eligible for telemedicine and telenursing strategies, preparation of COVID-19-free environments for healthcare professionals and patients, and support for educational actions to increase knowledge and adoption of safety behavior for healthcare professionals and patients were observed in the three reports. Discussion: A common element described in the reports is the implementation of actions to improve the safety of healthcare professionals, patients and the environment, as well as the continuity of cancer care. Scientific literature and recommendations of advisory boards, associations and organizations were supplementary to the measures applied. Conclusions: Social distancing due to the risk of COVID-19 spread proved to a successful field for the introduction of new health management and care in cancer treatment. Although there will certainly be loss and damage to cancer treatment processes during this pandemic, mapping the drop in cancer diagnosis, as well as treatment interruptions, is essential to mitigate any consequences.
How to cite this article: Teixeira, Tamara Otsuru Augustinho; Moura, Veronica Torel de; Santos, Gislene Padilha dos; Carneiro, Ieda Aparecida; Domenico, Edvane Birelo Lopes De. Pandemia de Covid-19 e atendimento especializado em oncologia: relato de experiência. Revista Cuidarte. 2021;12(2):e1377. http://dx.doi.org/10.15649/cuidarte.1377
References
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Acesso: Janeiro 31, 2021. Disponível em: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24; [Epub ahead of print]. https://doi.org/10.1001/jama.2020.2648 .
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;S0140-6736(20)31187-9. https://doi.org/10.1016/S0140-6736(20)31187-9
Governo do Estado de São Paulo. Governo de SP determina quarentena em todo o Estado, 21 de março, 2020. Acesso: Janeiro 31, 2021. Disponível em: https://www.saopaulo.sp.gov.br/ultimas-noticias/ao-vivo-governo-de-sp-anuncia-novas-medidas-para-combate-ao-coronavirus-no-estado/
Cidade de São Paulo. Prefeitura inicia montagem dos hospitais de campanha com dois mil leitos. Acesso: Fevereiro 10, 2021. Disponível em: http://www.capital.sp.gov.br/noticia/prefeitura-inicia-montagem-dos-hospitais-de-campanha-com-dois-mil-leitos
Trehan A, Jain R, Bansal D. Oncology care in a lower middle-income country during the COVID-19 pandemic. Pediatr Blood Cancer. 2020; 67(8):e28438. https://doi.org/10.1002/pbc.28438
Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, et al. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell. 2020; 38(5):629-646. https://doi.org/10.1016/j.ccell.2020.09.018
Hospital São Paulo - Associação Paulista para o desenvolvimento da Medicina. Nossa história. Acesso: Janeiro 31, 2021. Disponível em: http://www.spdm.org.br/a-empresa/conheca-a-spdm/nossa-historia
A Beneficência Portuguesa de São Paulo. Uma história de valorização da vida - Os 160 anos da BP - A Beneficência Portuguesa de São Paulo. Acesso: Janeiro 31, 2021. Disponível em: https://www.bp.org.br/institucional/sobre-a-bp
Hospital Alemão Oswaldo Cruz. O Hospital. Acesso: Janeiro 31, 2021. Disponível em: https://www.hospitaloswaldocruz.org.br/o-hospital
Governo do Estado de São Paulo. Rede Hebe Camargo de Combate ao Câncer. Acesso: Janeiro 31, 2021. Disponível em: http://www.saude.sp.gov.br/rede-hebe-camargo-de-combate-ao-cancer/
Faria MRT, Bergerot CD, De Domenico EBL. Perfil sociodemográfico e clínico de pacientes oncológicos que procuraram o serviço de pronto atendimento de um hospital público geral: estudo descritivo. Online Braz. J. Nurs. (Online) 2020 Jun; 19 (2):1-11.
Bergerot CD, Razavi M, Philip EJ, Bergerot PG, Soto-Perez-de-Celis E, De Domenico EBL, et al. Association between chemotherapy toxicity risk scores and physical symptoms among older Brazilian adults with cancer. J Geriatr Oncol. 2020 Mar;11(2):280-283. https://doi.org/10.1016/j.jgo.2019.07.006
American Society of Clinical Oncology. Special report: a guide to cancer care delivery during the COVID-19 pandemic. Acesso: Janeiro 31, 2021. Disponível em: https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf
European Society for Medical Oncology. Cancer Patient Management During The COVID-19. Acesso: Janeiro 31, 2021. Disponível em: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic
Sociedade Brasileira de Oncologia Clínica. Especial SBOC Coronavírus (COVID-19). Acesso: Janeiro 31, 2021. Disponível em: https://coronavirus.sboc.org.br/coronavirus/
Instituto Nacional de Câncer. INCA contra o coronavírus. Acesso: Janeiro 31, 2021. Disponível em: https://www.inca.gov.br/noticias/inca-contra-coronavirus
Mayor S. COVID-19: Impact on cancer workforce and delivery of care. Lancet Oncol. https://doi.org/10.1016/S1470-2045(20)30240-0
Instituto Nacional de Câncer. Portaria nº 467, de 20 de março de 2020. Acesso: Janeiro 31, 2021. Disponível em: http://www.in.gov.br/en/web/dou/-/portaria-n-467-de-20-de-marco-de-2020-249312996
Conselho Federal de Enfermagem. Resolução autoriza teleconsulta de Enfermagem durante a pandemia. Acesso: Janeiro 31, 2021. Disponível em: http://www.cofen.gov.br/resolucao-autoriza-teleconsulta-de-enfermagem-durante-a-pandemia_78350.html
Elkaddoum R, Gh Haddad F, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities. Future oncology 2020; 16(18): 1225–1227. https://doi.org/10.2217/fon-2020-0324
Union for International Cancer Control. Member organisation. Acesso: Janeiro 31, 2021. Disponível em: https://www.uicc.org/membership/instituto-oncoguia
Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E, et al. Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers. JCO Global Oncology 2020; 6:1046-1051. https://doi.org/10.1200/GO.20.00220
Nembhard IM, Burns LR, Shortell SM. Responding to Covid-19: Lessons from management research. NEJM Catalyst Innovations in Care Delivery. Acesso: Janeiro 31, 2021. Disponível em: https://catalyst.nejm.org/doi/pdf/10.1056/CAT.20.0111
Edmondson AC, Lei Z. Psychological Safety: The History, Renaissance, and Future of an Interpersonal Construct. Annu Rev Organ Psychol Organ Behav 2014; 1:23–43. https://doi.org/10.1146/annurev-orgpsych-031413-091305
Royal College of Physicians. COVID-19 and its impact on NHS workforce. Acesso: Janeiro 31, 2021. Disponível em: https://www.rcplondon.ac.uk/news/covid-19-and-its-impact-nhs-workforce
Oncology Nursing Society. ONS Interim Guidelines during the COVID-19 Pandemic. Acesso: Janeiro 31, 2021. Disponível em: https://www.ons.org/covid-19-interim-guidelines
European Oncology Nursing Society. Collaboration is key. Acesso: Janeiro 31, 2021. Disponível em: https://www.cancernurse.eu/collaboration-is-key-view-eons-covid-19-video/
Published
How to Cite
Issue
Section
Categories
Altmetrics
Downloads
License
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
